As rituximab biosimilars close in, Roche showcases Gazyva superiority
Roche faces competition against its blockbuster haematology drug
X
As rituximab biosimilars close in, Roche showcases Gazyva superiority
https://pharmaphorum.com/news/rituximab-biosimilars-close-roche-showcases-gazyva-superiority/